SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-015932
Filing Date
2017-03-21
Accepted
2017-03-21 21:51:54
Documents
1
Period of Report
2017-03-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v462248_4.html 4  
1 OWNERSHIP DOCUMENT v462248_4.xml 4 4146
  Complete submission text file 0001144204-17-015932.txt   5641
Mailing Address 205 EAST 42ND STREET, 16TH FLOOR NEW YORK NY 10017
Business Address 205 EAST 42ND STREET, 16TH FLOOR NEW YORK NY 10017 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROTROPE, INC. 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102
Business Address
Phares Shana (Reporting) CIK: 0001682239 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55275 | Film No.: 17705446